Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BUMP2BABY & ME+ (B2B&ME+): A Multi-Country, European Implementation Project to Reduce Adverse Birth Outcomes, Improve Maternal and Child Health and Reduce Non-Communicable Disease Risk

NCT07189221 is registered in ClinicalTrials.gov with University College Dublin as lead sponsor.

NCT NCT07189221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07189221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BUMP2BABY & ME+ (B2B&ME+): A Multi-Country, European Implementation Project to Reduce Adverse Birth Outcomes, Improve Maternal and Child Health and Reduce Non-Communicable Disease Risk
Lead sponsor
University College Dublin
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
May 31, 2028
Enrollment
3,600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus (gdm)